Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Gentamicin vs Oral Nitrofurantoin for Recurrent UTI
NCT06332781Phase 4Completed
- Sponsor
- Women & Infants Hospital
- Start
- Apr 2025
- Primary completion
- Sep 2025
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gentamicin in urinary tract infection (UTI) (2 arms), sponsored by Women & Infants Hospital. Primary endpoints: Feasibility of trial recruitment at 3 months, Treatment compliance at 3 months and 1 more. Started Apr 2025; status: completed.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06332781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332781.